IBT.LSE International Biotechnology Trust plc

Healthcare Capital Markets London Exchange
10.40 GBX
Close of Nov 3, 2026
787.60 1,217
Market cap
GBX 329M
P/E
4.3x
P/B
1.04x
ROE
108.4%
Dividend yield
3.03%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Feb 2026.

Is IBT.LSE undervalued?

Graham number
Price10.40
Graham value23.29
Discount55.3%

IBT.LSE trades 55.3% below its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

International Biotechnology Trust plc fundamental analysis

No fundamental analysis for International Biotechnology Trust plc yet.

International Biotechnology Trust plc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About International Biotechnology Trust plc

International Biotechnology Trust plc specializes in investments in development stage and late stage companies. The majority of the fund's assets are generally invested in smaller and mid-capitalization quoted companies, with a minority in larger capitalization quoted companies. It makes long only investments. It prefers to invest in quoted or unquoted biotechnology and life sciences companies focused on drug discovery and development and in related sectors such as microbiol…

Full company profile